Subcutaneous (SC) Interferon Beta Therapy in Multiple Sclerosis Patients and Characterization of Injection Site Reactions and Flu-Like Symptoms Under Daily Practice Setting
Latest Information Update: 05 Nov 2021
Price :
$35 *
At a glance
- Drugs Interferon beta-1b (Primary) ; Peginterferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- Acronyms PERFECT
- Sponsors Biogen
- 24 Sep 2019 Status changed from recruiting to completed.
- 20 Jun 2019 Planned primary completion date changed from 1 May 2019 to 30 Jun 2019.
- 21 Mar 2018 Status changed from not yet recruiting to recruiting.